Kidney Cancer Experts Meeting - In paralel with IKCC

Event for Physicians Oncologists, Urologists, Radiologists, Imagiologists, Psychologists and Nurses with clinical practice in renal cancer

Local Hotel Tivoli Oriente, Lisboa

Data 2019-04-05

Organização Academia CUF

Tipo Eventos Médicos

Contacto secretariado.academiacuf@jmellosaude.pt

The Kidney Cancer Experts Meeting, organized jointly by CUF Academic Research and Medical Center and CUF Instituto de Oncologia will be an opportunity to discuss in a multidisciplinary forum various topics of scientific and clinical interest, with emphasis on the most recent advances in the treatment of kidney cancer.  

 

The scientific meeting has a panel of some of the more relevant national and international medical researchers whose work has changed clinical practice in the treatment of kidney cancer.

 

We would like to highlight the presence of one of the world leaders in the treatment of advanced kidney cancer with immunotherapy, Eric Jonasch (MD Anderson Cancer Center, USA), Michael Jewett (one of the world leaders in the approach of "active surveillance") and Pedro Barata (from Tulane University, USA, involved in research into new cancer therapies based on molecular biology techniques).

 

 

O Kidney Cancer Experts Meeting, organizado em conjunto pela CUF Academic Research and Medical Center e CUF Instituto de Oncologia será um espaço para discutir vários tópicos de interesse científico e clínico, com ênfase nos mais recentes avanços no tratamento do cancro do rim - para tal a reunião científica conta, no seu painel de preletores, com alguns dos mais relevantes investigadores / clínicos  nacionais e internacionais, cujo trabalho tem alterado a prática clínica no tratamento do cancro rim.

 

De destacar a presença de um dos líderes mundiais no tratamento com imunoterapia do cancro do rim mestastizado, Eric Jonasch (MD Anderson Cancer Center, EUA), de Michael Jewett (um dos líderes mundiais na abordagem de "vigilância ativa") e de Pedro Barata (da Tulane University, EUA, envolvido na investigação de novas terapêuticas em cancro com base em técnicas de biologia molecular.

The language of the congress is English.

 

Registrations by invitation

Documentos
Program